Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Study of Cetuximab Combined With IMRT and Concurrent Chemotherapy of Cisplatin in Nasopharyngeal Carcinoma.

Next Previous
Search
Trial Profile

Phase II Study of Cetuximab Combined With IMRT and Concurrent Chemotherapy of Cisplatin in Nasopharyngeal Carcinoma.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cetuximab (Primary) ; Cisplatin
  • Indications Nasopharyngeal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ENCORE

Most Recent Events

  • 02 Jun 2015 Five-year follow-up results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
  • 31 Mar 2010 Additional lead trial centres identified as reported by ClinicalTrials.gov.
  • 31 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top